BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12231531)

  • 1. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood.
    Koike M; Hibi K; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2002 Sep; 8(9):2879-82. PubMed ID: 12231531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after resection in patients with esophageal cancer.
    Tanaka K; Yano M; Motoori M; Kishi K; Miyashiro I; Shingai T; Gotoh K; Noura S; Takahashi H; Ohue M; Yamada T; Ohigashi H; Yamamoto T; Yamasaki T; Doki Y; Ishikawa O
    Ann Surg Oncol; 2010 Oct; 17(10):2779-86. PubMed ID: 20411433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.
    Ikoma D; Ichikawa D; Ueda Y; Tani N; Tomita H; Sai S; Kikuchi S; Fujiwara H; Otsuji E; Yamagishi H
    Anticancer Res; 2007; 27(1B):535-9. PubMed ID: 17348438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis.
    Kaganoi J; Shimada Y; Kano M; Okumura T; Watanabe G; Imamura M
    Br J Surg; 2004 Aug; 91(8):1055-60. PubMed ID: 15286970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of disseminated cancer cells in rib marrow of patients with esophageal cancer.
    Noguchi T; Shibata T; Fumoto S; Sato T; Uchida Y; Daa T; Yokoyama S; Gabbert HE; Mueller W; Takeno S
    Oncol Rep; 2003; 10(3):623-7. PubMed ID: 12684634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma.
    Honma H; Kanda T; Ito H; Wakai T; Nakagawa S; Ohashi M; Koyama Y; Valera VA; Akazawa K; Hatakeyama K
    Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of circulating tumor cells in patients with esophageal cancer by real-time polymerase chain reaction.
    Ito H; Kanda T; Nishimaki T; Sato H; Nakagawa S; Hatakeyama K
    J Exp Clin Cancer Res; 2004 Sep; 23(3):455-64. PubMed ID: 15595636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
    Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
    Shimada Y; Maeda M; Watanabe G; Imamura M
    Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
    Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA.
    Kano M; Shimada Y; Kaganoi J; Sakurai T; Li Z; Sato F; Watanabe G; Imamura M
    Br J Cancer; 2000 Jan; 82(2):429-35. PubMed ID: 10646900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of CYFRA 21-1 for esophageal squamous cell carcinoma in radiation therapy.
    Wakatsuki M; Suzuki Y; Nakamoto S; Ohno T; Ishikawa H; Kiyohara H; Kiyozuka M; Shirai K; Nakayama Y; Nakano T
    J Gastroenterol Hepatol; 2007 May; 22(5):715-9. PubMed ID: 17444861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYFRA 21-1 serum analysis in patients with esophageal cancer.
    Brockmann JG; St Nottberg H; Glodny B; Heinecke A; Senninger NJ
    Clin Cancer Res; 2000 Nov; 6(11):4249-52. PubMed ID: 11106239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.
    Ishikawa N; Takano A; Yasui W; Inai K; Nishimura H; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
    Cancer Res; 2007 Dec; 67(24):11601-11. PubMed ID: 18089789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.